# Comparison of Standard and Alternative Antimonial Dosage in Patients With American Cutaneous Leishmaniasis

> **NCT01301924** · PHASE2,PHASE3 · COMPLETED · sponsor: **Oswaldo Cruz Foundation** · enrollment: 72 (actual)

## Conditions studied

- Cutaneous Leishmaniasis

## Interventions

- **DRUG:** Meglumine antimoniate

## Key facts

- **NCT ID:** NCT01301924
- **Lead sponsor:** Oswaldo Cruz Foundation
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-10
- **Primary completion:** 2016-04
- **Final completion:** 2017-12
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2018-05-15

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01301924

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01301924, "Comparison of Standard and Alternative Antimonial Dosage in Patients With American Cutaneous Leishmaniasis". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01301924. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*